These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32052692)

  • 1. Stability of ceftolozane and tazobactam in different peritoneal dialysis solutions.
    Harmanjeet H; Jani H; Zaidi STR; Wanandy T; Castelino RL; Sud K; Peterson GM; Patel RP
    Perit Dial Int; 2020 Sep; 40(5):470-476. PubMed ID: 32052692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of Meropenem and Piperacillin/Tazobactam with Heparin in Various Peritoneal Dialysis Solutions.
    Mendes K; Harmanjeet H; Sedeeq M; Modi A; Wanandy T; Zaidi STR; Ming LC; Castelino RL; Sud K; Peterson GM; Patel RP
    Perit Dial Int; 2018; 38(6):430-440. PubMed ID: 29991562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyridine levels in ceftazidime - peritoneal dialysis admixtures stored at body temperature.
    Nguyen TT; Harmanjeet H; Wanandy T; Castelino RL; Sud K; Jose MD; Peterson GM; Zaidi STR; Patel RP
    Perit Dial Int; 2020 Mar; 40(2):171-178. PubMed ID: 32063195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of Ceftazidime and Heparin in Four Different Types of Peritoneal Dialysis Solutions.
    Kandel S; Zaidi STR; Wanandy ST; Ming LC; Castelino RL; Sud K; Patel RP
    Perit Dial Int; 2018; 38(1):49-56. PubMed ID: 29162678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability and Compatibility of Antibiotics in Peritoneal Dialysis Solutions Applied to Automated Peritoneal Dialysis in The Pediatric Population.
    Deslandes G; Grégoire M; Bouquié R; Le Marec A; Allard S; Dailly E; Pineau A; Allain-Launay E; Jolliet P; Roussey G; Navas D
    Perit Dial Int; 2016 11-12; 36(6):676-679. PubMed ID: 27147292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of Tigecycline in Different Types of Peritoneal Dialysis Solutions.
    Robiyanto R; Zaidi ST; Shastri MD; Castelino RL; Wanandy ST; Jose MD; Patel RP
    Perit Dial Int; 2016; 36(4):410-4. PubMed ID: 26526051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of the combination of ceftazidime and cephazolin in icodextrin or pH neutral peritoneal dialysis solution.
    Patel RP; Shastri MD; Bakkari M; Wanandy T; Jose MD
    Perit Dial Int; 2014; 34(2):212-8. PubMed ID: 24385326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of Antibiotics for Intraperitoneal Administration in Extraneal 7.5% Icodextrin Peritoneal Dialysis Bags (STAB Study).
    Ranganathan D; Naicker S; Wallis SC; Lipman J; Ratanjee SK; Roberts JA
    Perit Dial Int; 2016; 36(4):421-6. PubMed ID: 26493753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of tobramycin and ceftazidime in icodextrin peritoneal dialysis solution.
    Pallotta KE; Elwell RJ; Nornoo AO; Manley HJ
    Perit Dial Int; 2009; 29(1):52-7. PubMed ID: 19164253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compatibility of Meropenem with Different Commercial Peritoneal Dialysis Solutions.
    Wiesholzer M; Winter A; Kussmann M; Zeitlinger M; Pichler P; Burgmann H; Reznicek G; Poeppl W
    Perit Dial Int; 2017 1-2; 37(1):51-55. PubMed ID: 27605684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of Cefepime in pH-Neutral Peritoneal Dialysis Solutions Packaged in Dual-Compartment Bags.
    Yousaf F; Zaidi ST; Wanandy T; Jose MD; Patel RP
    Perit Dial Int; 2016; 36(4):457-9. PubMed ID: 27385807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compatibility of fosfomycin with different commercial peritoneal dialysis solutions.
    Kussmann M; Baumann A; Hauer S; Pichler P; Zeitlinger M; Wiesholzer M; Burgmann H; Poeppl W; Reznicek G
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2237-2242. PubMed ID: 28685187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of moxifloxacin injection in peritoneal dialysis solution bags (Dianeal PD1 1.36% and Dianeal PD1 3.86%).
    Fernández-Varón E; Marín P; Espuny A; Villamayor L; Escudero E; Cárceles C
    J Clin Pharm Ther; 2006 Dec; 31(6):641-3. PubMed ID: 17176370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceftolozane/tazobactam: a novel cephalosporin/β-lactamase inhibitor combination with activity against multidrug-resistant gram-negative bacilli.
    Zhanel GG; Chung P; Adam H; Zelenitsky S; Denisuik A; Schweizer F; Lagacé-Wiens PR; Rubinstein E; Gin AS; Walkty A; Hoban DJ; Lynch JP; Karlowsky JA
    Drugs; 2014 Jan; 74(1):31-51. PubMed ID: 24352909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Pyridine Generation in Ceftazidime-Icodextrin Admixtures Used to Treat Peritoneal Dialysis-associated Peritonitis.
    Kaur H; Harmanjeet H; Wanandy T; Castelino RL; Sud K; Jose MD; Peterson GM; Patel RP
    Clin Ther; 2019 Nov; 41(11):2446-2451. PubMed ID: 31575441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of ceftazidime sodium and teicoplanin sodium in a peritoneal dialysis solution.
    Manduru M; Fariello A; White RL; Fox JL; Bosso JA
    Am J Health Syst Pharm; 1996 Nov; 53(22):2731-4. PubMed ID: 8931816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of cefepime in icodextrin peritoneal dialysis solution.
    Elwell RJ; Volino LR; Frye RF
    Ann Pharmacother; 2004 Dec; 38(12):2041-4. PubMed ID: 15494381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compatibility of linezolid with commercial peritoneal dialysis solutions.
    Poeppl W; Rainer-Harbach E; Kussmann M; Pichler P; Zeitlinger M; Wiesholzer M; Burgmann H; Reznicek G
    Am J Health Syst Pharm; 2018 Oct; 75(19):1467-1477. PubMed ID: 30257843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic stability in commercial peritoneal dialysis solutions: influence of formulation, storage and duration.
    Roberts DM; Fernando G; Singer RF; Kennedy KJ; Lawrence M; Talaulikar G
    Nephrol Dial Transplant; 2011 Oct; 26(10):3344-9. PubMed ID: 21324977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compatibility of aztreonam in four commercial peritoneal dialysis fluids.
    Tobudic S; Prager I; Kussmann M; Obermüller M; Ursli M; Zeitlinger M; Wiesholzer M; Burgmann H; Poeppl W; Reznicek G
    Sci Rep; 2020 Feb; 10(1):1788. PubMed ID: 32019947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.